1. P570 Safety and Effectiveness of Tofacitinib in Ulcerative Colitis: Real-world Data from TOFA-UC, a SN-IBD Study. (30th January 2023) Authors: Macaluso, F S; D'Antonio, E; Fries, W; Viola, A; Ksissa, O; Cappello, M; Muscarella, S; Belluardo, N; Giangreco, E; Mocciaro, F; Di Mitri, R; Ferracane, C; Vitello, A; Grova, M; Renna, S; Casà, A; Ventimiglia, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P760 Adalimumab biosimilars versus Azathioprine: indirect comparison of efficacy, safety and persistence in treatment. (30th January 2023) Authors: Saladino, M; Celsa, C; Amato, L M; Di Giorgio, F M; Muscarella, S; Melatti, P; Brinch, D; Cappello, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P848 Risk of Orthorexia Nervosa in Patients with Inflammatory Bowel Disease: A Link with Eating Disorders?. (30th January 2023) Authors: Di Giorgio, F M; Modica, S P; Ciminnisi, S; Saladino, M; Muscarella, S; Melatti, P; Brinch, D; Petta, S; Cappello, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i972 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗